Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 217

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Triple‐negative breast cancer in Hispanic patients: High prevalence, poor prognosis, and association with menopausal status, body mass index, and parity

Lara‐Medina, Fernando, Pérez‐Sánchez, Víctor, Saavedra‐Pérez, David, Blake‐Cerda, Monika, Arce, Claudia, Motola‐Kuba, Daniel, Villarreal‐Garza, Cynthia, González‐Angulo, Ana Maria, Bargalló, Enrique, Aguilar, Jose Luis, Mohar, Alejandro, Arrieta, Óscar · 2011 · Cancer

Abstract

BACKGROUND: Triple‐negative breast cancer (TNBC) is defined as breast cancer that is negative for estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2. TNBC represents 15% of all invasive breast cancers, but some studies have suggested that its prevalence differs between races. To the authors' knowledge, no previous studies have determined the prevalence of TNBC and its risk factors among Hispanic women. METHODS: The authors identified 2074 Hispanic women with breast cancer who attended the National Cancer Institute in Mexico City from 1998 to 2008. All histopathologic and immunohistochemical diagnoses were rereviewed by a breast cancer pathologist. The prevalence of TNBC, its association with clinicopathologic characteristics, and its prognostic impact were determined. RESULTS: The median patient age at diagnosis (±standard deviation) was 50 ± 12 years. The overall prevalence of TNBC was 23.1%. Younger age (P < .001), premenopausal status (P = .002), increased parity (P = .029), hormonal contraceptive use (P = .04) high histologic grade (P < .001), and advanced disease (P < .001) were associated independently with TNBC. Postmenopausal patients who had a body mass index (BMI) <25 kg/m 2 (P = .027) or <30 kg/m 2 (P < .001) were more likely to have TNBC. In multivariate analysis, patients with TNBC had a higher risk of locoregional recurrence (LRR), lower disease‐free survival (DFS) (hazard ratio, 1.62; 95% confidence interval, 1.13‐2.32; P = .009), and a lower cancer‐specific survival (CSS) rate (hazard ratio, 1.66; 95% confidence interval, 1.20‐2.30; P = .002) than patients with non‐TNBC. CONCLUSIONS: The median age at diagnosis of Hispanic women with breast cancer was 11 years younger than the average age reported in the United States. The prevalence of TNBC in this study population was higher than that reported in white women with breast cancer. TNBC was associated with a higher risk of LRR and with lower DFS and CSS than those in patients with non‐TNBC. Cancer 2011;. © 2011 American Cancer Society.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.25961

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 217

Metadata

Authors
Lara‐Medina, F., Pérez‐Sánchez, V., Saavedra‐Pérez, D., Blake‐Cerda, M., Arce, C., Motola‐Kuba, D., Villarreal‐Garza, C., González‐Angulo, A. M., Bargalló, E., Aguilar, J. L., Mohar, A., & Arrieta, Ó.
Venue
Cancer
Publisher
Wiley
Published
2011-03-08
Volume
117
Issue
16
Pages
3658-3669
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W2102379101
Cited by
217
References
3
FWCI
5.20
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Triple‐negative breast cancer in Hispanic patients: High prevalence, poor prognosis, and association with menopausal status, body mass index, and parity. https://app.cochat.ai/papers/10.1002/cncr.25961
The paper
Lara‐Medina, F., Pérez‐Sánchez, V., Saavedra‐Pérez, D., Blake‐Cerda, M., Arce, C., Motola‐Kuba, D., Villarreal‐Garza, C., González‐Angulo, A. M., Bargalló, E., Aguilar, J. L., Mohar, A., & Arrieta, Ó. (2011). Triple‐negative breast cancer in Hispanic patients: High prevalence, poor prognosis, and association with menopausal status, body mass index, and parity. Cancer. https://doi.org/10.1002/cncr.25961

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.